Ronald T Mitsuyasu - JoVE Visualize

Showing results (11-20 of 35) with videos related to

Pageof 4

Sort By:

Journal of Acquired Immune Deficiency Syndromes (1999)|March 16, 2013

Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphomaAnthony R Cillo, Amrita Krishnan, Ronald T Mitsuyasu, et al.

Journal of Cancer Epidemiology|November 25, 2016

Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral TherapyJeannette Y Lee, Ishwori Dhakal, Corey Casper, et al.

International Journal of STD & AIDS|June 15, 2014

High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot studyDeepa Reddy, Joseph Njala, Penny Stocker, et al.

Blood|March 31, 2012

Meeting the challenge of hematologic malignancies in sub-Saharan AfricaSatish Gopal, William A Wood, Stephanie J Lee, et al.

Clinical Immunology (Orlando, Fla.)|April 23, 2003

A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100-300 CD4+ T cellsAlberdina W de Boer, Norman Markowitz, H Clifford Lane, et al.

BMC Infectious Diseases|August 1, 2012

Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatmentSanjeev Sinha, Rahul C Shekhar, Gurjeet Singh, et al.

AIDS (London, England)|December 13, 2002

Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjectsPeter A Anton, Ronald T Mitsuyasu, Steven G Deeks, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2023

Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087)Missak Haigentz, Jeannette Y Lee, Elizabeth Y Chiao, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008

Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytesSteven Russell Fauce, Beth D Jamieson, Allison C Chin, et al.

Medicine|September 16, 2016

HIV and cancer registry linkage identifies a substantial burden of cancers in persons with HIV in IndiaSheela V Godbole, Karabi Nandy, Mansi Gauniyal, et al.

Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:

Pageof 4

Journal of Acquired Immune Deficiency Syndromes (1999)|March 16, 2013

Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphomaAnthony R Cillo, Amrita Krishnan, Ronald T Mitsuyasu, et al.

Journal of Cancer Epidemiology|November 25, 2016

Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral TherapyJeannette Y Lee, Ishwori Dhakal, Corey Casper, et al.

International Journal of STD & AIDS|June 15, 2014

High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot studyDeepa Reddy, Joseph Njala, Penny Stocker, et al.

Blood|March 31, 2012

Meeting the challenge of hematologic malignancies in sub-Saharan AfricaSatish Gopal, William A Wood, Stephanie J Lee, et al.

Clinical Immunology (Orlando, Fla.)|April 23, 2003

A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100-300 CD4+ T cellsAlberdina W de Boer, Norman Markowitz, H Clifford Lane, et al.

BMC Infectious Diseases|August 1, 2012

Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatmentSanjeev Sinha, Rahul C Shekhar, Gurjeet Singh, et al.

AIDS (London, England)|December 13, 2002

Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjectsPeter A Anton, Ronald T Mitsuyasu, Steven G Deeks, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2023

Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087)Missak Haigentz, Jeannette Y Lee, Elizabeth Y Chiao, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008

Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytesSteven Russell Fauce, Beth D Jamieson, Allison C Chin, et al.

Medicine|September 16, 2016

HIV and cancer registry linkage identifies a substantial burden of cancers in persons with HIV in IndiaSheela V Godbole, Karabi Nandy, Mansi Gauniyal, et al.

Pageof 4